Drugs / Antitumor B KAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05452408 | Dec 2026 → Dec 2027 | oral cavity squamous cell carcinoma | Medical College of Wisconsin | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antitumor B KAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05452408 ↗ |
| Route | Oral | “an oral agent” NCT05452408 ↗ |